Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Goshi Nishimura

Showing results (51-60 of 65) with videos related to

Pageof 7
Sort By:
Auris, Nasus, Larynx|June 14, 2011
Efficacy of fluoro-2-deoxy-D-glucose positron emission tomography to evaluate responses to concurrent chemoradiotherapy for head and neck squamous cell carcinomaMakiko Mori, Mamoru Tsukuda, Choichi Horiuchi, et al.
Auris, Nasus, Larynx|December 23, 2008
The efficacy and safety of concurrent chemoradiotherapy for maxillary sinus squamous cell carcinoma patientsGoshi Nishimura, Mamoru Tsukuda, Yasukazu Mikami, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|April 14, 2006
[Change of creatinine clearance rate in accordance with aging in Japanese patients with head and neck cancer]Goshi Nishimura, Choichi Horiuchi, Takafumi Yoshida, et al.
Japanese Journal of Clinical Oncology|October 1, 2014
Phase II study of concurrent chemoradiotherapy with S-1 in patients with stage II (T2N0M0) squamous cell carcinoma of the Pharynx or LarynxTakahide Taguchi, Masahiro Takahashi, Goshi Nishimura, et al.
International Journal of Clinical Oncology|February 25, 2016
Treatment results and prognostic factors for advanced squamous cell carcinoma of the head and neck treated with salvage surgery after concurrent chemoradiotherapyTakahide Taguchi, Goshi Nishimura, Masahiro Takahashi, et al.
Cancer Chemotherapy and Pharmacology|March 25, 2014
Treatment results and prognostic factors for advanced squamous cell carcinoma of the hypopharynx treated with concurrent chemoradiotherapyTakahide Taguchi, Goshi Nishimura, Masahiro Takahashi, et al.
Head & Neck|May 5, 2016
Prognostic significance of metabolic tumor volume in patients with piriform sinus carcinoma treated by radiotherapy with or without concurrent chemotherapyKenichiro Yabuki, Daisuke Sano, Osamu Shiono, et al.
Cancer Chemotherapy and Pharmacology|January 14, 2011
Efficacy and toxicity of concurrent chemoradiotherapy in patients with advanced oropharyngeal squamous cell carcinomaMakiko Mori, Mamoru Tsukuda, Hideki Matsuda, et al.
JMIR Research Protocols|August 25, 2018
Postoperative Bio-Chemoradiotherapy Using Cetuximab and Docetaxel in Patients With Cis-Platinum-Intolerant Core High-Risk Head and Neck Cancer: Protocol of a Phase 2 Nonrandomized Clinical TrialGoshi Nishimura, Hiromitsu Hatakeyama, Osamu Shiono, et al.
Cancer Letters|February 28, 2002
Reduction of in vivo tumor growth by MMI-166, a selective matrix metalloproteinase inhibitor, through inhibition of tumor angiogenesis in squamous cell carcinoma cell lines of head and neckHideaki Katori, Yuh Baba, Yukari Imagawa, et al.
Pageof 7

Showing results (51-60 of 65) with videos related to

Sort By:
Pageof 7
Auris, Nasus, Larynx|June 14, 2011
Efficacy of fluoro-2-deoxy-D-glucose positron emission tomography to evaluate responses to concurrent chemoradiotherapy for head and neck squamous cell carcinomaMakiko Mori, Mamoru Tsukuda, Choichi Horiuchi, et al.
Auris, Nasus, Larynx|December 23, 2008
The efficacy and safety of concurrent chemoradiotherapy for maxillary sinus squamous cell carcinoma patientsGoshi Nishimura, Mamoru Tsukuda, Yasukazu Mikami, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|April 14, 2006
[Change of creatinine clearance rate in accordance with aging in Japanese patients with head and neck cancer]Goshi Nishimura, Choichi Horiuchi, Takafumi Yoshida, et al.
Japanese Journal of Clinical Oncology|October 1, 2014
Phase II study of concurrent chemoradiotherapy with S-1 in patients with stage II (T2N0M0) squamous cell carcinoma of the Pharynx or LarynxTakahide Taguchi, Masahiro Takahashi, Goshi Nishimura, et al.
International Journal of Clinical Oncology|February 25, 2016
Treatment results and prognostic factors for advanced squamous cell carcinoma of the head and neck treated with salvage surgery after concurrent chemoradiotherapyTakahide Taguchi, Goshi Nishimura, Masahiro Takahashi, et al.
Cancer Chemotherapy and Pharmacology|March 25, 2014
Treatment results and prognostic factors for advanced squamous cell carcinoma of the hypopharynx treated with concurrent chemoradiotherapyTakahide Taguchi, Goshi Nishimura, Masahiro Takahashi, et al.
Head & Neck|May 5, 2016
Prognostic significance of metabolic tumor volume in patients with piriform sinus carcinoma treated by radiotherapy with or without concurrent chemotherapyKenichiro Yabuki, Daisuke Sano, Osamu Shiono, et al.
Cancer Chemotherapy and Pharmacology|January 14, 2011
Efficacy and toxicity of concurrent chemoradiotherapy in patients with advanced oropharyngeal squamous cell carcinomaMakiko Mori, Mamoru Tsukuda, Hideki Matsuda, et al.
JMIR Research Protocols|August 25, 2018
Postoperative Bio-Chemoradiotherapy Using Cetuximab and Docetaxel in Patients With Cis-Platinum-Intolerant Core High-Risk Head and Neck Cancer: Protocol of a Phase 2 Nonrandomized Clinical TrialGoshi Nishimura, Hiromitsu Hatakeyama, Osamu Shiono, et al.
Cancer Letters|February 28, 2002
Reduction of in vivo tumor growth by MMI-166, a selective matrix metalloproteinase inhibitor, through inhibition of tumor angiogenesis in squamous cell carcinoma cell lines of head and neckHideaki Katori, Yuh Baba, Yukari Imagawa, et al.
Pageof 7